Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities-Reference-Cited by-同舟云学术

Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities

Published:2019-05 Issue:5 Volume:16 Page:534-539
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Nichols Dave P.¹,Durmowicz Anthony G.²,Field Ann²,Flume Patrick A.³,VanDevanter Donald R.⁴,Mayer-Hamblett Nicole¹

Affiliation:

1. Cystic Fibrosis Therapeutics Development Network Coordinating Center, Department of Pediatrics, Seattle Children’s Hospital, University of Washington School of Medicine, Seattle, Washington

2. Cystic Fibrosis Foundation, Bethesda, Maryland

3. Department of Medicine and Pediatrics, Medical University of South Carolina, Charleston, South Carolina; and

4. Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1513/AnnalsATS.201812-863OT

Reference31 articles.

1. Cystic fibrosis

2. Origins of Cystic Fibrosis Lung Disease

3. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry

4. Predictors of mortality in adults with cystic fibrosis

5. Antimicrobial molecules in the lung: formulation challenges and future directions for innovation

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The environmental burden of inhalation;European Journal of Pharmaceutical Sciences;2024-09

2. Inhaled antimicrobial prescribing for Pseudomonas aeruginosa infections in Europe;Journal of Cystic Fibrosis;2024-05

3. Insights on Pseudomonas aeruginosa Carbohydrate Binding from Profiles of Cystic Fibrosis Isolates Using Multivalent Fluorescent Glycopolymers Bearing Pendant Monosaccharides;Microorganisms;2024-04-16

4. Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: Challenges, recent advances, and future perspectives;Journal of Drug Delivery Science and Technology;2024-04

5. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis;Infectious Disease Clinics of North America;2024-03